INDEPENDENT CLINICAL TRIAL AGREEMENT FOR THE DRUG(S)Independent Clinical Trial Agreement • November 21st, 2022
Contract Type FiledNovember 21st, 2022, in quality of (indicate whether General manager, CEO, Extraordinary commissioner, etc.) who has been duly empowered to sign this deed on , (title of signatory) (hereinafter referred to as “ ”)
INDEPENDENT CLINICAL TRIAL AGREEMENT FOR THE DRUG(S) BETWEEN ANDIndependent Clinical Trial Agreement • November 21st, 2022
Contract Type FiledNovember 21st, 2022The Institute/Company/Foundation/Association ______ headquartered in __________, Tax Code and VAT _________ (hereinafter “Sponsor”) in the person of the General Manager Legal representative (or delegated person), on the one hand, as Sponsor
INDEPENDENT CLINICAL TRIAL AGREEMENT FOR THE DRUGSIndependent Clinical Trial Agreement • November 17th, 2022
Contract Type FiledNovember 17th, 2022, in quality of (indicate whether General manager, CEO, Extraordinary commissioner, etc.) who has been duly empowered to sign this deed on , (title of signatory) (hereinafter referred to as “ ”)
INDEPENDENT CLINICAL TRIAL AGREEMENT FOR THE DRUGS BETWEEN ANDIndependent Clinical Trial Agreement • November 16th, 2022
Contract Type FiledNovember 16th, 2022The Institute/Company/Foundation/Association ______ headquartered in __________, Tax Code and VAT _________ (hereinafter “Sponsor”) in the person of the General Manager Legal representative (or delegated person), on the one hand, as Sponsor